Nara Medical University   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Kashihara Japan (1945)

Organization Overview

First Clinical Trial
2002
NCT00110448
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

First Department of Internal Medicine, Nara Medical University | Nara Medical University | Professor of Medicine, First Department of Internal Medicine, Nara Medical University

Active Ingredients

Drugs in Phase 4 Trials (4)

acetylsalicylic acid (aspirin) (1 trial)

atrial natriuretic peptide (1 trial)

azilsartan (edarbi) (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 3 Trials (1)

folic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arteriosclerosis (Phase 4)

Atherosclerosis (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Heart Failure (Phase 4)

Hypertension (Phase 4)

Renal Insufficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5